Ken Griffin Globus Medical Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Globus Medical Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 19,500 shares of GMED stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,500

Previous 70,000 72.14%

Holding current value

$1.62 Million

Previous $4.79 Million 70.9%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.08 - $73.92 $54.1 Million - $59.6 Million	806,296 Added 103.33%	1,586,624 $114 Million
Q2 2024 Aug 14, 2024	BUY	$49.79 - $68.85 $10.4 Million - $14.3 Million	208,399 Added 36.44%	780,328 $53.4 Million
Q1 2024 May 15, 2024	BUY	$51.15 - $56.52 $23.7 Million - $26.2 Million	462,770 Added 423.94%	571,929 $30.7 Million
Q4 2023 Feb 14, 2024	BUY	$43.79 - $55.14 $193,332 - $243,443	4,415 Added 4.22%	109,159 $5.82 Million
Q3 2023 Nov 14, 2023	SELL	$49.1 - $62.37 $9.32 Million - $11.8 Million	-189,788 Reduced 64.44%	104,744 $5.2 Million
Q2 2023 Aug 14, 2023	SELL	$52.61 - $59.54 $43.9 Million - $49.7 Million	-834,133 Reduced 73.9%	294,532 $17.5 Million
Q1 2023 May 15, 2023	BUY	$51.83 - $79.63 $51.7 Million - $79.4 Million	997,390 Added 759.77%	1,128,665 $63.9 Million
Q4 2022 Feb 14, 2023	SELL	$58.4 - $75.53 $782,443 - $1.01 Million	-13,398 Reduced 9.26%	131,275 $9.75 Million
Q3 2022 Nov 14, 2022	BUY	$55.32 - $67.54 $6.94 Million - $8.47 Million	125,382 Added 649.95%	144,673 $8.62 Million
Q2 2022 Aug 15, 2022	SELL	$53.08 - $81.37 $3.88 Million - $5.95 Million	-73,087 Reduced 79.12%	19,291 $1.08 Million
Q1 2022 May 16, 2022	BUY	$63.68 - $75.54 $2.21 Million - $2.62 Million	34,647 Added 60.01%	92,378 $6.82 Million
Q4 2021 Feb 14, 2022	BUY	$62.62 - $79.92 $2.48 Million - $3.17 Million	39,627 Added 218.89%	57,731 $4.17 Million
Q3 2021 Nov 15, 2021	SELL	$76.41 - $84.06 $4.16 Million - $4.58 Million	-54,496 Reduced 75.06%	18,104 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$61.85 - $77.53 $861,261 - $1.08 Million	13,925 Added 23.73%	72,600 $5.63 Million
Q1 2021 May 17, 2021	SELL	$60.05 - $67.74 $8.6 Million - $9.71 Million	-143,276 Reduced 70.95%	58,675 $3.62 Million
Q4 2020 Feb 16, 2021	BUY	$48.89 - $65.87 $8.59 Million - $11.6 Million	175,630 Added 667.26%	201,951 $13.2 Million
Q3 2020 Nov 16, 2020	SELL	$45.26 - $57.82 $3.39 Million - $4.34 Million	-74,975 Reduced 74.02%	26,321 $1.3 Million
Q2 2020 Aug 14, 2020	BUY	$39.81 - $55.61 $1.44 Million - $2 Million	36,054 Added 55.26%	101,296 $4.83 Million
Q1 2020 May 15, 2020	SELL	$35.06 - $59.45 $5.66 Million - $9.6 Million	-161,526 Reduced 71.23%	65,242 $2.78 Million
Q4 2019 Feb 14, 2020	BUY	$49.45 - $59.5 $10.3 Million - $12.4 Million	207,810 Added 1096.16%	226,768 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$40.41 - $52.32 $1.89 Million - $2.45 Million	-46,758 Reduced 71.15%	18,958 $969,000
Q2 2019 Aug 14, 2019	SELL	$39.3 - $48.41 $3.67 Million - $4.52 Million	-93,326 Reduced 58.68%	65,716 $2.78 Million
Q1 2019 May 15, 2019	BUY	$38.08 - $49.41 $5.84 Million - $7.58 Million	153,312 Added 2675.6%	159,042 $0
Q4 2018 Feb 14, 2019	SELL	$41.38 - $57.44 $3.32 Million - $4.6 Million	-80,168 Reduced 93.33%	5,730 $247,000
Q2 2018 Aug 10, 2018	BUY	$47.96 - $57.41 $2.03 Million - $2.43 Million	42,293 Added 96.99%	85,898 $0
Q1 2018 May 11, 2018	BUY	$42.75 - $51.73 $1.47 Million - $1.78 Million	34,488 Added 378.28%	43,605 $2.17 Million
Q4 2017 Feb 09, 2018	SELL	$28.86 - $41.64 $140,144 - $202,203	-4,856 Reduced 34.75%	9,117 $375,000
Q3 2017 Nov 09, 2017	BUY	$28.28 - $30.85 $395,156 - $431,067	13,973	13,973 $415,000

Others Institutions Holding GMED

# of Institutions

479

Shares Held

104M

Call Options Held

183K

Put Options Held

57.3K

View Full List

About GLOBUS MEDICAL INC

Ticker GMED
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 77,037,200
Market Cap $6.4B
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...

More about GMED

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account